Table 1.
The Expression of Antigen in Tumor Tissue by the immunohistochemical Observations
Antigen expression | Score | Experimental group | ||
---|---|---|---|---|
Control (n=8) | Gemcitabine (20 mg/kg) (n=8) | GM (100mg/kg) (n=8) | ||
% (n) | %(n) | % (n) | ||
Cytokeratin 19 antigen (CK 19) | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
1 | 0 (0.0) | 4 (50.0) | 3 (37.5) | |
2 | 6 (75) | 2 (25.0) | 2 (25) | |
3 | 1 (12.5) | 1 (12.5) | 2 (25) | |
4 | 1 (12.5) | 1 (12.5) | 1 (12.5) | |
Proliferating cell nuclear antigen (PCNA) | 0 | 0 (0.0) | 5 (62.5)* | 4 (50)* |
1 | 0 (0.0) | 3 (37.5) | 3 (37.5) | |
2 | 1 (12.5) | 0 (0.0) | 1 (12.5) | |
3 | 4 (12.5) | 0 (0.0) | 0 (0.0) | |
4 | 3 (37.5) | 0 (0.0) | 0 (0.0) |
Score: 0, no or a few positive area (< 10%); 1, positive area (< 25%); 2, no or a few positive area (< 50%); 3, no or a few positive area (< 75%); 4, no or a few positive area (> 75%); Significantly different compared with untreated control at the same time point
(p< 0.05)